The Ragon Institute of MGH, MIT and Harvard have used flexible funding and a collaborative approach to identify a key weakness in the HIV virus.
Young women and expecting mothers are one of the most-affected groups, and research has shown that HIV/AIDS can significantly increase the chances of both maternal deaths and still births. One Massachusetts General Hospital Discovery Foundation Fellow has witnessed the disease’s impact first-hand and is determined to help and give back to her community.
In recognition of World AIDS Day, we are sharing some recent work from the Ragon Institute of MGH, MIT and Harvard, which was established in 2009 with a dual mission to contribute to the accelerated discovery of an HIV/AIDS vaccine and to serve as a world leader in the collaborative study of immunology.
Researchers at the Ragon Institute of Massachusetts General Hospital, MIT and Harvard recently published an editorial in Science Immunology detailing their efforts to combine basic science and social good to reduce the high rate of HIV infection in young South African women while simultaneously empowering them. Here is a brief summary.
During the month of March, Massachusetts General Hospital is celebrating Women’s History Month by highlighting our outstanding women scientists, physicians and staff members. In the coming weeks we’ll be sharing a few of their profiles, and be sure to visit the women’s history month landing page to see the full series. Julie Levison, MD, MPH, […]
World AIDS Day takes place on the 1st of December each year. It’s an opportunity to highlight the success of worldwide efforts to combat HIV/AIDS, as well as the importance of continued support for these efforts. Researchers and clinicians, including those at Massachusetts General Hospital, acknowledge that although great strides have been made in the clinical […]
Mass General researchers working to stop the spread of infectious disease are worried that proposed cuts to the NIH budget would eliminate a key resource for global health efforts. Back in the 1950s, there was a global effort to control mosquito populations with the hope of eradicating mosquito-borne diseases such as malaria and yellow fever. […]
As HIV therapies have improved in recent decades, we are now seeing the first generation of youth who were born with the disease, or acquired it shortly after birth, live to adulthood.